Research Article

Development and Validation of RP-HPLC Method for the Determination of Hydrochlorothiazide in Bulk Drug and Pharmaceutical Dosage Form

Table 3

Comparison among the proposed method and other HPLC methods in the literature applied to HCTZ.

MethodDetectorColumnMobile phaseFlow rate (mL/min)Detection wavelength (min)Recovery %LinearityLODLOQ

B P [19]UVODS C18, (100 × 4.6 mm)
3 µm
MeOH : H2O
(50 : 50 v/v)
0.8224 nm8
Ref [8]UVHypersil (ODS 250 × 4.6 mm, 5 µm)ACN : Buffer1.0215 nm3.037110020–120 µg/mL ( = 0.9980)0.644 µg/mL1.951 µg/mL
Ref [20]UVHypersil ODS C18 (250 × 4.6 mm, 5 µm)MeOH : Buffer
(60 : 40 v/v)
1.0270 nm2100.1260–140 µg/mL ( = 0.9990)10 µg/mL15 µg/mL
Ref [21]DADHypersil ODS C18 (100 × 4.0 mm, 3 µm)ACN : Buffer (18 : 72 v/v)0.3220 nm694–100.22–50 µg/mL ( = 0.9998)2 µg/mL
Ref [22]UVPhenomenex ODS2, C18, (250 × 4.6 mm, 5 µm)TEA : ACN : MeOH (50 : 25 : 25 v/v)2.0235 nm2.18399200–300 µg/mL ( = 0.9996)3.40 µg/mL10.31 µg/mL
Ref [23]UV-VisPhenomenex C18 (150 × 4.6 mm, 5 µm)MeOH : orthophosphoric acid (50 : 50 v/v)0.6271 nm3.49101.121–10 µg/mL ( = 0.9872)0.05 µg/mL0.5 µg/mL
Ref [24]UVODS C18 (250 × 4.6 mm × 5 µm)ACN : Buffer (50 : 50 v/v)1.0226 nm2.994–11280–120 µg/mL ( = 0.999)3.3 µg/mL10 µg/mL
Ref [25]PDAInertsil ODS3 (250 × 4.6 mm, 5 µm)ACN : Buffer (20 : 80 v/v)1.0220 nm7.694–1055–25 g/mL ( = 0.996)0.007 g/mL0.022 g/mL
Ref [26]UVXterra (250 × 4.6 mm, 5 µm)ACN : Buffer (gradient elution)1.5265 nm100–1020.00625–0.15 µg/mL ( = 0.9999)0.008 µg/mL0.075 µg/mL
Ref [27]UV-VisPhenomenex Luna C18 (150 × 4.6 mm, 5 µm)ACN : MeOH : buffer (20 : 50 : 30 v/v)1.0250 nm3.34100.21–10 µg/mL ( = 0.9997)0.164 µg/mL0.5 µg/mL
Ref [28]PDAXterra ODS C18 (4.6 × 150 × 5 µm)H2O : MeOH (50 : 50 v/v)0.8230 nm2.442100–10250–150 µg/mL ( = 0.999)0.00003 µg0.0001 µg
Ref [29]UV-VisZorbax C18 (4.6 × 250 mm, 5 µm)Buffer : ACN : TEA
(95 : 5 : 0.1 v/v)
0.9280 nm4.489101.17 ± 11.25–25 µg/mL ( = 0.9992)1.012 µg/mL3.067 µg/mL
Ref [30]UV-VisPhenomenex Gemini C18 (250 × 4.6 mm × 5 µm)Buffer : MeOH : ACN (30 : 35 : 35 v/v)1.5240 nm2.298.9920–30 µg/mL ( = 0.9980)54.13 µg/mL164.03 µg/mL
Ref [31]UVHypersil BDS, (250 × 4.6 mm, 5 µm)ACN : TEA (40 : 60 v/v)1.0228 nm3.3100 ± 26.25–37.5 µg/mL ( = 0.9999)0.075 µg/mL0.224 µg/mL
Ref [32]PDAPhenomenex Gemini C18 (250 × 4.6 mm, 5 µm)ACN : Buffer (70 : 30 v/v)1.0254 nm4.2598.652.5–12.5 µg/mL ( = 0.9995)5.0 ng/mL15 ng/mL
Ref [33]PDAHypersil BDS C18 (250 × 4.6 mm, 5 µm)MeOH/ACN
(70 : 30 v/v)
1.0254 nm3.410020–80 µg/mL ( = 0.999)0.13 µg/mL0.05 µg/mL
Present studyPDAInertsil ODS3 C18, (4.6 × 250 mm, 5 µm)ACN : H2O (50 : 50 v/v)1.0272 nm3.599.932–30 µg/mL ( ≥ 0.9978)0.5 µg/mL1.7 µg/mL